1. Home
  2. TLSI vs ZUMZ Comparison

TLSI vs ZUMZ Comparison

Compare TLSI & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • ZUMZ
  • Stock Information
  • Founded
  • TLSI 2010
  • ZUMZ 1978
  • Country
  • TLSI United States
  • ZUMZ United States
  • Employees
  • TLSI N/A
  • ZUMZ N/A
  • Industry
  • TLSI Medical Specialities
  • ZUMZ Clothing/Shoe/Accessory Stores
  • Sector
  • TLSI Health Care
  • ZUMZ Consumer Discretionary
  • Exchange
  • TLSI Nasdaq
  • ZUMZ Nasdaq
  • Market Cap
  • TLSI 204.0M
  • ZUMZ 211.6M
  • IPO Year
  • TLSI N/A
  • ZUMZ 2005
  • Fundamental
  • Price
  • TLSI $5.54
  • ZUMZ $12.54
  • Analyst Decision
  • TLSI Strong Buy
  • ZUMZ Hold
  • Analyst Count
  • TLSI 5
  • ZUMZ 1
  • Target Price
  • TLSI $10.90
  • ZUMZ $25.00
  • AVG Volume (30 Days)
  • TLSI 39.7K
  • ZUMZ 302.4K
  • Earning Date
  • TLSI 08-13-2025
  • ZUMZ 06-05-2025
  • Dividend Yield
  • TLSI N/A
  • ZUMZ N/A
  • EPS Growth
  • TLSI N/A
  • ZUMZ N/A
  • EPS
  • TLSI N/A
  • ZUMZ 0.04
  • Revenue
  • TLSI $32,141,000.00
  • ZUMZ $896,157,000.00
  • Revenue This Year
  • TLSI $55.52
  • ZUMZ $3.31
  • Revenue Next Year
  • TLSI $54.76
  • ZUMZ $1.34
  • P/E Ratio
  • TLSI N/A
  • ZUMZ $323.53
  • Revenue Growth
  • TLSI 46.20
  • ZUMZ 3.01
  • 52 Week Low
  • TLSI $3.50
  • ZUMZ $11.31
  • 52 Week High
  • TLSI $6.08
  • ZUMZ $31.37
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 53.07
  • ZUMZ 51.44
  • Support Level
  • TLSI $5.18
  • ZUMZ $11.67
  • Resistance Level
  • TLSI $5.54
  • ZUMZ $12.58
  • Average True Range (ATR)
  • TLSI 0.32
  • ZUMZ 0.68
  • MACD
  • TLSI 0.01
  • ZUMZ 0.04
  • Stochastic Oscillator
  • TLSI 82.81
  • ZUMZ 61.41

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

Share on Social Networks: